Cyncron (previously Medicon), was founded in 1985 and is a full service phase I-IV drug development company with the aim of complementing the quality, efficacy and safety of clinical trials, through optimisation of clinical trial organisation and management.

Cyncron has its headquarters in Copenhagen and offices in Sweden and Finnland. With the good track record of Cyncron in large phase III outcome studies, this collaboration strengthens our competitiveness and possibilities and attracts clients needing an experienced European partner for their drug development. Together, we deliver large projects that neither of us could handle alone as quickly and effectively.

For further information, see www.Cyncron.com